Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomised, placebo-controlled trial

The requested reference [a224c8513430b85d99b2386aafa1256eb7701514] no longer exists in our database. It has been replaced by the current reference: [c1535005781cdfdbaafd8812bfea846ae3029229]

Authors
Category Primary study
Year 1995
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. The authors conclude that administration of Epo during the first days of life reduces the requirement for transfusions and is cost-saving.
Epistemonikos ID: b35561ead49aba647e088cc7d6231d199623814b
First added on: Apr 19, 2023